Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.740
+0.040 (0.85%)
Dec 20, 2024, 4:00 PM EST - Market closed
Adverum Biotechnologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 99 | 76 | 58 | 173 | 1,057 | 744 | |
| Market Cap Growth | -3.61% | 31.60% | -66.54% | -83.65% | 42.01% | 275.72% | |
| Enterprise Value | 19 | 34 | -40 | -38 | 633 | 609 | |
| Last Close Price | 4.74 | 7.53 | 5.79 | 17.60 | 108.40 | 115.20 | |
| PS Ratio | 80.99 | 21.13 | - | 23.03 | - | 2976.22 | |
| PB Ratio | 0.68 | 0.91 | 0.32 | 0.55 | 2.43 | 4.25 | |
| P/TBV Ratio | 1.01 | 0.91 | 0.32 | 0.55 | 2.43 | 4.25 | |
| EV/Sales Ratio | 18.63 | 9.58 | - | - | - | 2437.97 | |
| Debt / Equity Ratio | 0.51 | 0.90 | 0.59 | 0.33 | 0.07 | 0.18 | |
| Asset Turnover | 0.00 | 0.01 | - | 0.02 | - | 0.00 | |
| Quick Ratio | 5.54 | 3.87 | 5.76 | 14.58 | 20.59 | 8.55 | |
| Current Ratio | 5.82 | 4.13 | 5.91 | 14.88 | 20.82 | 9.06 | |
| Return on Equity (ROE) | -76.26% | -88.43% | -62.10% | -38.78% | -38.57% | -34.29% | |
| Return on Assets (ROA) | -29.83% | -32.14% | -25.12% | -19.66% | -20.90% | -19.64% | |
| Return on Capital (ROIC) | -32.50% | -34.62% | -26.56% | -20.51% | -21.93% | -20.96% | |
| Earnings Yield | -95.44% | -154.06% | -267.40% | -84.25% | -11.12% | -8.67% | |
| FCF Yield | -87.28% | -120.59% | -207.48% | -71.18% | -8.62% | -9.20% | |
| Buyback Yield / Dilution | -70.02% | -1.58% | -1.24% | -15.14% | -32.83% | -4.44% | |
| Total Shareholder Return | -70.02% | -1.58% | -1.24% | -15.14% | -32.83% | -4.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.